Company news
Corestemchemon Inc. (KRX:166480) news
Corestemchemon Inc. news releases on 6ix. Latest, Sep 17, 2025: Neuronata-R® Phase 3 Results Confirm Subgroup Benefit at PACTALS 2025, Strengthening…
Press releases & updates
Neuronata-R® Phase 3 Results Confirm Subgroup Benefit at PACTALS 2025, Strengthening Biomarker-Driven Pathway
September 16, 2025
CorestemChemon Expands Global CRO Reach with ATG Lifetech, Targeting Next-Gen Preclinical Services
July 19, 2025
Neuronata-R® Stem Cell Therapy Shows Promise in ALS Phase 3 Subgroup Analysis, Moves Toward FDA Accelerated Approval
May 29, 2025